Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Alkermes - 33 Year Stock Price History | ALKS

Historical daily share price chart and data for Alkermes since 1991 adjusted for splits and dividends. The latest closing stock price for Alkermes as of November 12, 2024 is 29.23.
  • The all-time high Alkermes stock closing price was 98.05 on March 01, 2000.
  • The Alkermes 52-week high stock price is 32.88, which is 12.5% above the current share price.
  • The Alkermes 52-week low stock price is 22.06, which is 24.5% below the current share price.
  • The average Alkermes stock price for the last 52 weeks is 26.62.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Alkermes Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 26.7043 28.6200 32.5600 23.0100 29.2300 5.37%
2023 28.1991 25.8700 33.6300 23.3700 27.7400 6.16%
2022 25.8508 24.1500 31.8700 21.9400 26.1300 12.34%
2021 24.3680 19.7400 32.1300 18.2100 23.2600 16.59%
2020 17.6377 19.7600 22.1000 13.0600 19.9500 -2.21%
2019 25.4200 29.1100 37.3300 17.2900 20.4000 -30.87%
2018 45.9911 55.2200 67.2600 27.9400 29.5100 -46.08%
2017 54.8201 56.1000 61.6600 47.6900 54.7300 -1.53%
2016 45.4797 74.8300 75.2700 29.0500 55.5800 -29.98%
2015 66.3880 58.2400 80.1400 55.0800 79.3800 35.55%
2014 47.3686 40.2400 58.8800 40.0700 58.5600 44.02%
2013 30.2678 19.2800 41.1200 19.2800 40.6600 119.55%
2012 18.1842 17.3400 20.8800 15.1200 18.5200 6.68%
2011 15.4301 12.5500 19.5200 12.1400 17.3600 41.37%
2010 12.4457 9.7100 15.9200 9.6900 12.2800 30.50%
2009 9.6079 10.7100 13.1300 7.5600 9.4100 -11.64%
2008 12.2140 15.1000 16.8900 6.1000 10.6500 -31.69%
2007 15.7875 13.0900 18.5600 12.7600 15.5900 16.60%
2006 18.9792 20.5200 26.7100 13.1800 13.3700 -30.07%
2005 14.4015 14.0100 19.6600 10.0100 19.1200 35.70%
2004 13.3925 13.9700 16.8600 8.5100 14.0900 4.37%
2003 11.0874 6.6600 15.5600 6.5200 13.5000 115.31%
2002 15.1033 25.7500 30.3400 3.7800 6.2700 -76.21%
2001 26.8799 27.6300 37.1000 17.5000 26.3600 -16.00%
2000 41.5542 25.5000 98.0500 23.6250 31.3800 27.74%
1999 15.7511 11.6900 26.8150 11.4400 24.5650 121.41%
1998 9.9991 9.9400 13.3750 5.3150 11.0950 11.62%
1997 9.5169 11.1900 14.6900 5.1900 9.9400 -14.49%
1996 6.2174 3.7500 12.1250 3.7500 11.6250 192.89%
1995 2.4000 1.0315 4.3125 1.0000 3.9690 273.55%
1994 2.4714 3.6875 4.5000 1.0625 1.0625 -69.64%
1993 4.1401 4.5000 5.5000 3.1250 3.5000 -17.65%
1992 6.0673 9.0000 14.1900 2.7500 4.2500 -52.78%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.729B $1.663B
Alkermes plc, formed by the merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies (EDT), is a fully integrated global biopharmaceutical company that utilizes proprietary technologies to research, develop and commercialize, both with partners and on its own pharmaceutical products in major therapeutic areas. Alkermes holds a diversified product portfolio and a promising pipeline of candidates targeting major central nervous system (CNS) disorders including schizophrenia, depression, addiction and multiple sclerosis. Alkermes derives revenues on net sales of its proprietary products: Vivitrol & Aristada, and manufacturing and/or royalty revenues on net sales of products commercialized by the company's partners. These include Risperdal Consta, Invega Sustenna/Xeplion, Invega Trinza/Trevicta, Ampyra/Fampyra and Bydureon. Interesting late-stage candidate in the company's pipeline include nemvaleukin alfa developed for treating advanced solid tumors. Its proprietary drugs are Vivitrol & Aristada.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $160.636B 15.55
Vertex Pharmaceuticals (VRTX) United States $126.189B 0.00
Bristol Myers Squibb (BMY) United States $119.703B 50.44
Gilead Sciences (GILD) United States $117.465B 21.30
Regeneron Pharmaceuticals (REGN) United States $90.219B 20.53
CSL (CSLLY) Australia $89.966B 0.00
GSK (GSK) United Kingdom $73.617B 8.52
Argenex SE (ARGX) Netherlands $35.516B 0.00
Alnylam Pharmaceuticals (ALNY) United States $34.689B 0.00
BioNTech SE (BNTX) Germany $25.489B 0.00
Biogen (BIIB) United States $24.522B 10.53
Illumina (ILMN) United States $23.413B 85.33
BeiGene (BGNE) Cayman Islands $18.860B 0.00
Moderna (MRNA) United States $16.728B 0.00
Incyte (INCY) United States $15.524B 0.00
Genmab (GMAB) Denmark $14.870B 21.82
BioMarin Pharmaceutical (BMRN) United States $12.603B 29.26
Insmed (INSM) United States $12.548B 0.00
Vaxcyte (PCVX) United States $12.386B 0.00
Bio-Techne Corp (TECH) United States $11.823B 45.65
Sarepta Therapeutics (SRPT) United States $10.920B 98.55
Exelixis (EXEL) United States $10.238B 23.28
Revolution Medicines (RVMD) United States $9.980B 0.00
QIAGEN (QGEN) Netherlands $9.865B 20.30
Intra-Cellular Therapies (ITCI) United States $9.381B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Exact Sciences (EXAS) United States $9.283B 0.00
Roivant Sciences (ROIV) United Kingdom $8.608B 0.00
Repligen (RGEN) United States $8.322B 108.46
Ascendis Pharma (ASND) Denmark $7.742B 0.00
Halozyme Therapeutics (HALO) United States $7.584B 17.13
Legend Biotech (LEGN) United States $7.325B 0.00
Viking Therapeutics (VKTX) United States $6.753B 0.00
Cytokinetics (CYTK) United States $6.631B 0.00
Blueprint Medicines (BPMC) United States $6.138B 0.00
Nuvalent (NUVL) United States $5.896B 0.00
Avidity Biosciences (RNA) United States $5.575B 0.00
Arcellx (ACLX) United States $5.433B 0.00
Krystal Biotech (KRYS) United States $5.385B 89.15
ADMA Biologics Inc (ADMA) United States $5.077B 54.45
Biohaven (BHVN) United States $4.761B 0.00
Axsome Therapeutics (AXSM) United States $4.725B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.418B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.330B 0.00
Denali Therapeutics (DNLI) United States $4.302B 0.00
Immunovant (IMVT) United States $4.296B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.937B 0.00
Guardant Health (GH) United States $3.673B 0.00
Apellis Pharmaceuticals (APLS) United States $3.640B 0.00
Merus (MRUS) Netherlands $3.535B 0.00
ImmunityBio (IBRX) United States $3.448B 0.00
Edgewise Therapeutics (EWTX) United States $3.333B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.315B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.287B 0.00
Kymera Therapeutics (KYMR) United States $3.238B 0.00
Amicus Therapeutics (FOLD) United States $3.134B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.118B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.047B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.983B 22.99
Iovance Biotherapeutics (IOVA) United States $2.953B 0.00
Zai Lab (ZLAB) China $2.885B 0.00
Janux Therapeutics (JANX) United States $2.773B 0.00
Vericel (VCEL) United States $2.759B 931.50
IDEAYA Biosciences (IDYA) United States $2.678B 0.00
Vera Therapeutics (VERA) United States $2.661B 0.00
Twist Bioscience (TWST) United States $2.652B 0.00
Keros Therapeutics (KROS) United States $2.628B 0.00
Apogee Therapeutics (APGE) United States $2.581B 0.00
Protagonist Therapeutics (PTGX) United States $2.573B 16.23
Belite Bio (BLTE) United States $2.484B 0.00
CG Oncology (CGON) United States $2.481B 0.00
SpringWorks Therapeutics (SWTX) United States $2.458B 0.00
Geron (GERN) United States $2.400B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.323B 0.00
Beam Therapeutics (BEAM) United States $2.314B 0.00
Ligand Pharmaceuticals (LGND) United States $2.281B 56.95
Bavarian Nordic (BVNRY) Denmark $2.277B 12.19
Akero Therapeutics (AKRO) United States $2.260B 0.00
Scholar Rock Holding (SRRK) United States $2.134B 0.00
Structure Therapeutics (GPCR) United States $2.115B 0.00
NeoGenomics (NEO) United States $2.096B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.017B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.001B 16.63
WAVE Life Sciences (WVE) Singapore $1.982B 0.00
Fortrea Holdings (FTRE) United States $1.969B 62.71
MannKind (MNKD) United States $1.953B 50.57
NovoCure (NVCR) Jersey $1.928B 0.00
Nurix Therapeutics (NRIX) United States $1.915B 0.00
Disc Medicine (IRON) United States $1.880B 0.00
Spyre Therapeutics (SYRE) United States $1.842B 0.00
Neumora Therapeutics (NMRA) United States $1.810B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.810B 0.00
Arvinas (ARVN) United States $1.808B 0.00
Galapagos (GLPG) Belgium $1.800B 0.00
Celldex Therapeutics (CLDX) United States $1.792B 0.00
Dynavax Technologies (DVAX) United States $1.775B 103.85
Certara (CERT) United States $1.706B 48.18
Intellia Therapeutics (NTLA) United States $1.696B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.688B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.660B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.577B 0.00
Praxis Precision Medicines (PRAX) United States $1.546B 0.00
Arcus Biosciences (RCUS) United States $1.535B 0.00
Gyre Therapeutics (GYRE) United States $1.496B 0.00
Myriad Genetics (MYGN) United States $1.472B 0.00
Travere Therapeutics (TVTX) United States $1.463B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.461B 0.00
Kura Oncology (KURA) United States $1.444B 0.00
Viridian Therapeutics (VRDN) United States $1.433B 0.00
Upstream Bio (UPB) United States $1.414B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.384B 0.00
Novavax (NVAX) United States $1.354B 0.00
ANI Pharmaceuticals (ANIP) United States $1.284B 17.48
Vir Biotechnology (VIR) United States $1.274B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.200B 0.00
Zymeworks (ZYME) United States $1.198B 0.00
Bicara Therapeutics (BCAX) United States $1.157B 0.00
Applied Therapeutics (APLT) United States $1.152B 0.00
Cogent Biosciences (COGT) United States $1.136B 0.00
Mesoblast (MESO) Australia $1.136B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.114B 0.00
ArriVent BioPharma (AVBP) United States $1.108B 0.00
MiMedx (MDXG) United States $1.096B 28.69
LENZ Therapeutics (LENZ) United States $1.024B 0.00
Immatics (IMTX) Germany $1.012B 0.00
Septerna (SEPN) $0.990B 0.00
CARGO Therapeutics (CRGX) United States $0.970B 0.00
89BIO (ETNB) United States $0.960B 0.00
Prothena (PRTA) Ireland $0.934B 0.00
Cullinan Therapeutics (CGEM) United States $0.933B 0.00
Castle Biosciences (CSTL) United States $0.918B 163.90
Cytek Biosciences (CTKB) United States $0.907B 0.00
Rapport Therapeutics (RAPP) United States $0.887B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.886B 0.00
Adaptive Biotechnologies (ADPT) United States $0.875B 0.00
AbCellera Biologics (ABCL) Canada $0.874B 0.00
Erasca (ERAS) United States $0.845B 0.00
Pliant Therapeutics (PLRX) United States $0.841B 0.00
Replimune (REPL) United States $0.833B 0.00
Zenas BioPharma (ZBIO) United States $0.820B 0.00
Dianthus Therapeutics (DNTH) United States $0.819B 0.00
Liquidia Technologies (LQDA) United States $0.816B 0.00
Tyra Biosciences (TYRA) United States $0.807B 0.00
Avid Bioservices (CDMO) United States $0.780B 0.00
Pacira BioSciences (PCRX) United States $0.776B 7.30
Anavex Life Sciences (AVXL) United States $0.765B 0.00
MBX Biosciences (MBX) United States $0.759B 0.00
Immunome (IMNM) United States $0.750B 0.00
Entrada Therapeutics (TRDA) United States $0.741B 12.45
Nuvation Bio (NUVB) United States $0.730B 0.00
Oric Pharmaceuticals (ORIC) United States $0.724B 0.00
Stoke Therapeutics (STOK) United States $0.721B 0.00
BioAge Labs (BIOA) United States $0.717B 0.00
CorMedix Inc (CRMD) United States $0.708B 0.00
Tectonic Therapeutic (TECX) United States $0.704B 0.00
Annexon (ANNX) United States $0.698B 0.00
Arbutus Biopharma (ABUS) United States $0.690B 0.00
Third Harmonic Bio (THRD) United States $0.678B 0.00
IGM Biosciences (IGMS) United States $0.673B 0.00
Mineralys Therapeutics (MLYS) United States $0.665B 0.00
Olema Pharmaceuticals (OLMA) United States $0.661B 0.00
AnaptysBio (ANAB) United States $0.654B 0.00
Abivax SA (ABVX) France $0.654B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.651B 0.00
CureVac (CVAC) Germany $0.645B 5.24
Sinovac Biotech (SVA) China $0.645B 0.00
Humacyte (HUMA) United States $0.640B 0.00
Sana Biotechnology (SANA) United States $0.634B 0.00
Astria Therapeutics (ATXS) United States $0.630B 0.00
Oculis Holding AG (OCS) Switzerland $0.607B 0.00
Allogene Therapeutics (ALLO) United States $0.595B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.595B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.591B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.590B 0.00
Emergent Biosolutions (EBS) United States $0.590B 0.00
ACELYRIN, INC (SLRN) United States $0.587B 0.00
Sangamo Therapeutics (SGMO) United States $0.564B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.561B 0.00
ChromaDex (CDXC) United States $0.554B 725.00
Celcuity (CELC) United States $0.553B 0.00
PureTech Health (PRTC) United States $0.547B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.544B 0.00
Alector (ALEC) United States $0.544B 0.00
Pharming Group (PHAR) Netherlands $0.543B 0.00
Alumis (ALMS) United States $0.536B 0.00
Q32 Bio (QTTB) United States $0.532B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.530B 0.00
Aura Biosciences (AURA) United States $0.528B 0.00
Neurogene (NGNE) United States $0.520B 0.00
REGENXBIO (RGNX) United States $0.520B 0.00
Prime Medicine (PRME) United States $0.519B 0.00
Contineum Therapeutics (CTNM) United States $0.505B 0.00
Terns Pharmaceuticals (TERN) United States $0.504B 0.00
Foghorn Therapeutics (FHTX) United States $0.493B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.491B 0.00
GH Research (GHRS) Ireland $0.476B 0.00
GRAIL (GRAL) United States $0.469B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.466B 0.00
Revance Therapeutics (RVNC) United States $0.433B 0.00
MeiraGTx Holdings (MGTX) United States $0.432B 0.00
Cartesian Therapeutics (RNAC) United States $0.430B 0.00
BioStem Technologies (BSEM) $0.415B 36.74
Absci (ABSI) United States $0.413B 0.00
Northwest Biotherapeutics (NWBO) United States $0.399B 0.00
Design Therapeutics (DSGN) United States $0.391B 0.00
C4 Therapeutics (CCCC) United States $0.389B 0.00
EnGene Holdings (ENGN) Canada $0.377B 0.00
MaxCyte (MXCT) United States $0.373B 0.00
Voyager Therapeutics (VYGR) United States $0.372B 9.62
XOMA Royalty (XOMA) United States $0.368B 0.00
Jasper Therapeutics (JSPR) United States $0.361B 0.00
Kamada (KMDA) Israel $0.360B 23.22
Tango Therapeutics (TNGX) United States $0.360B 0.00
Poseida Therapeutics (PSTX) United States $0.360B 0.00
Alpha Teknova (TKNO) United States $0.340B 0.00
Rezolute (RZLT) United States $0.337B 0.00
ITeos Therapeutics (ITOS) United States $0.336B 0.00
Sutro Biopharma (STRO) United States $0.334B 0.00
UniQure (QURE) Netherlands $0.328B 0.00
Codexis (CDXS) United States $0.327B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.325B 0.00
Semper Paratus Acquisition (TVGN) United States $0.323B 0.00
Artiva Biotherapeutics (ARTV) United States $0.317B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.315B 0.00
Nautilus Biotechnology (NAUT) United States $0.313B 0.00
Zura Bio (ZURA) United States $0.304B 0.00
AC Immune (ACIU) Switzerland $0.303B 0.00
Ocugen (OCGN) United States $0.294B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.293B 0.00
ATyr Pharma (ATYR) United States $0.293B 0.00
Biomea Fusion (BMEA) United States $0.290B 0.00
Urogen Pharma (URGN) United States $0.290B 0.00
Prima BioMed (IMMP) Australia $0.288B 0.00
TScan Therapeutics (TCRX) United States $0.287B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.283B 0.00
Atea Pharmaceuticals (AVIR) United States $0.281B 0.00
Fate Therapeutics (FATE) United States $0.271B 0.00
Mersana Therapeutics (MRSN) United States $0.270B 0.00
Kodiak Sciences (KOD) United States $0.267B 0.00
Abeona Therapeutics (ABEO) United States $0.264B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.264B 0.00
GENFIT S.A (GNFT) France $0.260B 0.00
Lifecore Biomedical (LFCR) United States $0.259B 0.00
Climb Bio (CLYM) United States $0.255B 0.00
Editas Medicine (EDIT) United States $0.253B 0.00
Anika Therapeutics (ANIK) United States $0.247B 0.00
Compass Therapeutics (CMPX) United States $0.246B 0.00
Inozyme Pharma (INZY) United States $0.242B 0.00
Opthea (OPT) Australia $0.241B 0.00
Precigen (PGEN) United States $0.240B 0.00
Inhibrx Biosciences (INBX) United States $0.240B 0.00
Eton Pharmaceuticals (ETON) United States $0.237B 0.00
Trevi Therapeutics (TRVI) United States $0.231B 0.00
CAMP4 Therapeutics (CAMP) United States $0.229B 0.00
Fulcrum Therapeutics (FULC) United States $0.227B 0.00
Amarin (AMRN) Ireland $0.227B 0.00
Kyverna Therapeutics (KYTX) United States $0.225B 0.00
2seventy Bio (TSVT) United States $0.220B 0.00
Solid Biosciences (SLDB) United States $0.220B 0.00
Instil Bio (TIL) United States $0.217B 0.00
XBiotech (XBIT) United States $0.216B 0.00
Nkarta (NKTX) United States $0.215B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.214B 0.00
Caribou Biosciences (CRBU) United States $0.212B 0.00
Nuvectis Pharma (NVCT) United States $0.212B 0.00
Cabaletta Bio (CABA) United States $0.210B 0.00
Molecular Partners AG (MOLN) Switzerland $0.209B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.203B 0.00
ScPharmaceuticals (SCPH) United States $0.197B 0.00
Verastem (VSTM) United States $0.196B 0.00
Gossamer Bio (GOSS) United States $0.192B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.191B 0.00
DiaMedica Therapeutics (DMAC) United States $0.184B 0.00
Black Diamond Therapeutics (BDTX) United States $0.183B 0.00
Sagimet Biosciences (SGMT) United States $0.182B 0.00
Greenwich LifeSciences (GLSI) United States $0.178B 0.00
Actuate Therapeutics (ACTU) United States $0.176B 0.00
Bright Minds Biosciences (DRUG) United States $0.176B 0.00
Tenaya Therapeutics (TNYA) United States $0.175B 0.00
Adverum Biotechnologies (ADVM) United States $0.164B 0.00
Skye Bioscience (SKYE) United States $0.164B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.161B 0.00
Cardiff Oncology (CRDF) United States $0.161B 0.00
Akoya Biosciences (AKYA) United States $0.158B 0.00
Puma Biotechnology (PBYI) United States $0.158B 6.69
Checkpoint Therapeutics (CKPT) United States $0.155B 0.00
Innate Pharma S.A (IPHA) France $0.154B 0.00
Repare Therapeutics (RPTX) Canada $0.149B 0.00
Ventyx Biosciences (VTYX) United States $0.148B 0.00
Oncobiologics (OTLK) United States $0.148B 0.00
PepGen (PEPG) United States $0.148B 0.00
Scilex Holding (SCLX) United States $0.148B 0.00
Vigil Neuroscience (VIGL) United States $0.147B 0.00
Candel Therapeutics (CADL) United States $0.143B 0.00
Compugen (CGEN) Israel $0.143B 80.00
Seer (SEER) United States $0.139B 0.00
Inventiva S.A (IVA) France $0.139B 0.00
Rani Therapeutics Holdings (RANI) United States $0.137B 0.00
Generation Bio (GBIO) United States $0.137B 0.00
Inovio Pharmaceuticals (INO) United States $0.134B 0.00
Elutia (ELUT) United States $0.129B 0.00
INmune Bio (INMB) United States $0.126B 0.00
Allakos (ALLK) United States $0.122B 0.00
Alto Neuroscience (ANRO) United States $0.121B 0.00
Coya Therapeutics (COYA) United States $0.121B 0.00
Invivyd (IVVD) United States $0.119B 0.00
Adherex Technologies (FENC) United States $0.116B 0.00
23andMe Holding (ME) United States $0.115B 0.00
Adlai Nortye (ANL) Cayman Islands $0.115B 0.00
Benitec Biopharma (BNTC) United States $0.115B 0.00
Seres Therapeutics (MCRB) United States $0.113B 0.00
MediciNova (MNOV) United States $0.112B 0.00
FibroBiologics (FBLG) United States $0.111B 0.00
Cellectis S.A (CLLS) France $0.110B 0.00
PDS Biotechnology (PDSB) United States $0.109B 0.00
Adagene (ADAG) China $0.108B 0.00
BioAtla (BCAB) United States $0.106B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.105B 0.00
Annovis Bio (ANVS) United States $0.104B 0.00
Immunic (IMUX) United States $0.104B 0.00
Genelux (GNLX) United States $0.102B 0.00
Renovaro (RENB) United States $0.102B 0.00
X4 Pharmaceuticals (XFOR) United States $0.100B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.100B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.099B 0.00
Adicet Bio (ACET) United States $0.099B 0.00
HilleVax (HLVX) United States $0.099B 0.00
Werewolf Therapeutics (HOWL) United States $0.096B 0.00
Coherus BioSciences (CHRS) United States $0.095B 0.00
Cidara Therapeutics (CDTX) United States $0.095B 0.00
Monopar Therapeutics (MNPR) United States $0.091B 0.00
Chimerix (CMRX) United States $0.089B 0.00
InflaRx (IFRX) Germany $0.089B 0.00
Ovid Therapeutics (OVID) United States $0.088B 0.00
Genenta Science S.p.A (GNTA) Italy $0.088B 0.00
Galena Biopharma (SLS) United States $0.087B 0.00
I-Mab (IMAB) China $0.086B 0.00
Oncolytics Biotech (ONCY) Canada $0.086B 0.00
Ikena Oncology (IKNA) United States $0.085B 0.00
Celularity (CELU) United States $0.084B 0.00
Leap Therapeutics (LPTX) United States $0.083B 0.00
Aileron Therapeutics (ALRN) United States $0.083B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
Cue Biopharma (CUE) United States $0.083B 0.00
Boundless Bio (BOLD) United States $0.083B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.082B 0.00
VistaGen Therapeutics (VTGN) United States $0.082B 0.00
CytomX Therapeutics (CTMX) United States $0.081B 6.12
Eupraxia Pharmaceuticals (EPRX) Canada $0.079B 0.00
TELA Bio (TELA) United States $0.077B 0.00
Aerovate Therapeutics (AVTE) United States $0.077B 0.00
Bluebird Bio (BLUE) United States $0.076B 0.00
ZIVO Bioscience (ZIVO) United States $0.074B 0.00
Syros Pharmaceuticals (SYRS) United States $0.073B 0.00
CervoMed (CRVO) United States $0.073B 0.00
Quince Therapeutics (QNCX) United States $0.073B 0.00
BeyondSpring (BYSI) United States $0.073B 0.00
Spero Therapeutics (SPRO) United States $0.071B 3.22
ALX Oncology Holdings (ALXO) United States $0.071B 0.00
Vor Biopharma (VOR) $0.068B 0.00
Agenus (AGEN) United States $0.067B 0.00
Precision BioSciences (DTIL) United States $0.064B 0.00
Omega Therapeutics (OMGA) United States $0.063B 0.00
DBV Technologies S.A (DBVT) France $0.061B 0.00
IO Biotech (IOBT) Denmark $0.061B 0.00
Rapt Therapeutics (RAPT) United States $0.061B 0.00
Enzo Biochem (ENZ) United States $0.061B 0.00
Shattuck Labs (STTK) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Theratechnologies (THTX) Canada $0.058B 0.00
OnKure Therapeutics (OKUR) United States $0.058B 0.00
Connect Biopharma Holdings (CNTB) United States $0.057B 0.00
Atara Biotherapeutics (ATRA) United States $0.057B 0.00
Affimed (AFMD) Germany $0.057B 0.00
Aligos Therapeutics (ALGS) United States $0.057B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.056B 0.00
Kronos Bio (KRON) United States $0.055B 0.00
Kezar Life Sciences (KZR) United States $0.055B 0.00
Immuneering (IMRX) United States $0.054B 0.00
Elicio Therapeutics (ELTX) United States $0.054B 0.00
Aadi Bioscience (AADI) United States $0.053B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.051B 0.00
Xilio Therapeutics (XLO) United States $0.047B 0.00
Immix Biopharma (IMMX) United States $0.047B 0.00
BGM Group (BGM) China $0.047B 0.00
Intensity Therapeutics (INTS) United States $0.047B 0.00
Imunon (IMNN) United States $0.047B 0.00
Rallybio (RLYB) United States $0.046B 0.00
HOOKIPA Pharma (HOOK) United States $0.043B 0.00
NextCure (NXTC) United States $0.043B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.043B 0.00
VTv Therapeutics (VTVT) United States $0.042B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.042B 0.00
Passage Bio (PASG) United States $0.041B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.041B 0.00
Elevation Oncology (ELEV) United States $0.041B 0.00
Fortress Biotech (FBIO) United States $0.039B 0.00
Lantern Pharma (LTRN) United States $0.039B 0.00
Lumos Pharma (LUMO) United States $0.038B 0.00
Dare Bioscience (DARE) United States $0.038B 0.00
CalciMedica (CALC) United States $0.038B 0.00
OKYO Pharma (OKYO) $0.037B 0.00
Lexaria Bioscience (LEXX) Canada $0.036B 0.00
Clene (CLNN) United States $0.036B 0.00
Dyadic (DYAI) United States $0.034B 0.00
Longeveron (LGVN) United States $0.033B 0.00
KALA BIO (KALA) United States $0.033B 0.00
Eyenovia (EYEN) United States $0.032B 0.00
Grace Therapeutics (GRCE) Canada $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
SAB Biotherapeutics (SABS) United States $0.032B 0.00
Athira Pharma (ATHA) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Equillium (EQ) United States $0.030B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.030B 0.00
Opus Genetics (IRD) United States $0.030B 0.00
LakeShore Biopharma (LSB) China $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Estrella Immunopharma (ESLA) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
GeoVax Labs (GOVX) United States $0.027B 0.00
BioXcel Therapeutics (BTAI) United States $0.027B 0.00
Chemomab Therapeutics (CMMB) Israel $0.027B 0.00
RenovoRx (RNXT) United States $0.026B 0.00
Ocean Biomedical (OCEA) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.025B 0.00
Curis (CRIS) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Cognition Therapeutics (CGTX) United States $0.024B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.024B 0.00
Beyond Air (XAIR) United States $0.023B 0.00
BRIACELL THERAP (BCTX) Canada $0.023B 0.00
Femasys (FEMY) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
UNITY Biotechnology (UBX) United States $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Spruce Biosciences (SPRB) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
Gelteq (GELS) $0.021B 0.00
Cadrenal Therapeutics (CVKD) United States $0.019B 0.00
Cara Therapeutics (CARA) United States $0.019B 0.00
Aprea Therapeutics (APRE) United States $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
BioAffinity Technologies (BIAF) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Tenax Therapeutics (TENX) United States $0.017B 0.00
IN8bio (INAB) United States $0.016B 0.00
Sensei Biotherapeutics (SNSE) United States $0.014B 0.00
Cingulate (CING) United States $0.013B 0.00
Turnstone Biologics (TSBX) United States $0.013B 0.00
Evaxion Biotech (EVAX) Denmark $0.013B 0.00
Apollomics (APLM) United States $0.013B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Evogene (EVGN) Israel $0.011B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Vincerx Pharma (VINC) United States $0.010B 0.00
Biora Therapeutics (BIOR) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Galecto (GLTO) Denmark $0.009B 0.00
NKGen Biotech (NKGN) United States $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Forte Biosciences (FBRX) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
TuHURA Biosciences (HURA) United States $0.008B 0.00
Edesa Biotech (EDSA) Canada $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.006B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
Carmell (CTCX) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Exicure (XCUR) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Dogwood Therapeutics (DWTX) United States $0.005B 0.00
Polyrizon (PLRZ) $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Onconetix (ONCO) United States $0.001B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Elevai Labs (ELAB) United States $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00